Volume 17, Number 8—August 2011
Dispatch
Human Parvovirus 4 as Potential Cause of Encephalitis in Children, India
Table 2
Patient or genotype | Genotype 3, aa (nt), n = 1 | Genotype 2, aa (nt), n = 7 | Genotype 1, aa (nt), n = 11 | VES085 serum, aa (nt), n = 1 | VES085 CSF, aa (nt), n = 1 | VES065 CSF, aa (nt), n = 1 | |
---|---|---|---|---|---|---|---|
VES065 CSF, n = 1 | 9.5 (3.5) | 3.7 (1.5) | 10.3 (3.7) | 0.2 (0.0) | 0.2 (0.0) | ||
VES085 CSF, n = 1 | 9.4 (3.5) | 3.6 (1.5) | 10.2 (3.7) | 0.0 (0.0) | |||
VES085 serum, n = 1 | 9.4 (3.5) | 3.6 (1.5) | 10.2 (3.7) | ||||
Genotype 1, n = 11 | 8.0 (2.6) | 9.3 (2.9) | 0.9 (0.6) | ||||
Genotype 2, n = 7 | 8.6 (2.7) | 1.8 (0.7) | |||||
Genotype 3, n = 1 |
*PARV4, human parvovirus 4; CSF, cerebrospinal fluid.
Page created: August 15, 2011
Page updated: August 15, 2011
Page reviewed: August 15, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.